New biosimilar pathway for insulin aims to promote lower prices, competition

Guidance documents released by the FDA on Tuesday outlining a new pathway for biologic products will help promote competition and lower prices for drugs with historically high list prices, including insulin and human growth hormone, according to a statem https://www.healio.com/endocrinology/diabetes/news/online/%7B4815c7c8-78cf-4710-a66f-46230dfc0c6c%7D/new-biosimilar-pathway-for-insulin-aims-to-promote-lower-prices-competition